FDA
- Status: approved
Glycopyrronium in Combination With Tropisetron (Glycopyrronium in Combination With Tropisetron) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
The Second Affiliated Hospital of Chongqing Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.